Current biomarkers used in research and in clinical practice in Alzheimer's Disease (AD) are
the analysis of cerebral spinal fluid (CSF) to detect levels of Aβ42 and phosphorylated-tau …

Quantitative electroencephalography (EEG) provides useful information about
neurophysiological health of the aging brain. Current studies investigating EEG coherence …

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers and quantitative EEG show particular
patterns of change in Alzheimer's disease (AD) and reflect neuropathologic processes and …

Background Quantitative electroencephalography (QEEG) is a reliable and non-invasive
diagnostic tool to quantify cortical synaptic injury or loss in the clinical assessment of …

Objectives The present study aims to compare early-onset Alzheimer's disease (EOAD)
patients with healthy controls (HC), and late-onset Alzheimer's disease (LOAD) patients …

Objective To assess the relevance of quantitative EEG (qEEG) measures as outcomes of
disease severity and progression in Parkinson disease (PD). Methods Main databases were …

Background: Several studies investigated clinical and instrumental differences to make
diagnosis of dementia in general and in Alzheimer's disease (AD) in particular with the aim …

Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by cognitive
deficits, problems in activities of daily living, and behavioral disturbances …

Alzheimer's disease (AD) is a progressive disorder affecting intellectual, behavioral and
functional abilities. It is associated with age and pathological alterations leading to the …

Healthy aging is associated with impairment in cognitive information processing. Several
neuroimaging methods such as functional magnetic resonance imaging, positron emission …